1Bhatnager PK, Papas E, Blum HE, etal. Immune response to synthetic peptic analogues of hepatitis B surface antigen specific for the "a" determinant[J]. Proc Natl Acad Sci USA, 1982,79:4400-4404.
2Waters JA, O'Rourker SM, Richardson SC, etal. Qualitative analysis of the humoral immune response to the "a" determinant of HBs antigen after inoculation with plasma-derived or recombinant vaccine[J]. J Med Virol, 1987.21 : 155-160.
3Neurath AR, Kent SBH, Parker K, et al. Antibodies to a synthetic peptide from the preS 120-145 region of the hepatitis B virus envelope are virus-neutralizing[J]. Vaccine, 1986,435-37.
4Neurath AR, Kent SBH, Strick N, et al. Identification and chemical synthesis of a host cell binding site on hepatitis B virus[J]. Cell, 1986,46:429-436.
5Guidotti LG, Ando MV, Hobbs T, et al. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice[J]. Proc Natl Acad Sci USA, 1994,91:3764.
6Guidotti LG, Guilhot S, Chisari FV. Interleukin-2 and interferon α/β downregulate hepatitis B virus gene expression in vivo by tumor necrosis factor dependent and independent pathways[J]. J Virol, 1994,68 : 1265.
7Guidotti LG, Matzke B, Schaller H, et al. High level hepatitis B virus replication in transgenic mice[J]. J Virol, 1995,69:1265.
9Tlollais P, Charmay P, Vyas GN. Biology of the hepatitis Bvirus[J]. Science, 1981,213:408-441.
10Penna AF, Chisari A, Bertoletti G, et al. Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen[J]. J Exp Med, 1991,174:1565.
